<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01531374</url>
  </required_header>
  <id_info>
    <org_study_id>10037989DOC REV 1C</org_study_id>
    <nct_id>NCT01531374</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement</brief_title>
  <official_title>Medtronic CoreValve® Continued Access Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the safety and efficacy of the Medtronic CoreValve®
      System in the treatment of symptomatic severe aortic stenosis in subjects who have a
      predicted very high risk and high risk for aortic valve surgery.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause Death or Major Stroke (Extreme Risk- Medtronic CoreValve® System); All-cause Mortality (High Risk Surgical- Medtronic CoreValve® System vs. Surgical Valve)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>MACCE is defined as a composite of:
All-Cause Death
Myocardial Infarction (MI)
All Stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Occurrence of Individual MACCE Components</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>Individual MACCE Components Include:
All Cause Mortality
MI
All stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Events (MAEs)</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>MAEs Include:
MACCE
Acute Kidney Injury
Cardiac Tamponade
Prosthetic Valve Dysfunction
Cardiogenic Shock
Valve Endocarditis
Life-Threatening, Disabling or Major Bleeding
Major Vascular Complication
Cardiac Perforation
Device Migration/Valve Embolism</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Conduction Disturbance Requiring Permanent Pacemaker Implantation</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in NYHA Class</measure>
    <time_frame>Baseline to 30 days, baseline to 6 months, baseline to 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
NYHA Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Distance Walked During 6-Minute Walk Test (6MWT)</measure>
    <time_frame>Baseline to 30 days, baseline to 1 year</time_frame>
    <description>Change in distance walked during 6MWT from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of Days Alive Out of Hospital at 365 Days Post Procedure Versus Total Days Alive</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL) Change</measure>
    <time_frame>30 day, 6 month, 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
12 Item Short Form Health Survey (SF-12): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic Assessment of Valve Performance</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>Using the following measure:
• Effective Orifice Area (EOA) analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic Assessment of Valve Performance</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>Using the following measure:
• Transvalvular Mean Gradient analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic Assessment of Valve Performance</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular) analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic Valve Hospitalizations</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Deaths and Valve-Related Deaths</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strokes and Transient Ischemic Attacks (TIAs)</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>Strokes (of any severity) and TIAs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Index Procedure Related MAEs</measure>
    <time_frame>Procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Index Procedure Hospital Stay</measure>
    <time_frame>Number of days from admission to discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Success</measure>
    <time_frame>Number of days from admission to discharge</time_frame>
    <description>Defined as:
Successful vascular access, delivery and deployment of the device, and successful retrieval of the delivery system,
Correct position of the device in the proper anatomical location (placement in the annulus with no impedance on device function),
Intended performance of the prosthetic valve (aortic valve area &gt; 1.2 cm2 for 26, 29 and 31mm valves, ≥ 0.9 cm2 for 23mm valve (by echocardiography using the continuity equation) and mean aortic valve gradient &lt; 20 mmHg or peak velocity &lt; 3 m/sec, without moderate or severe prosthetic valve aortic regurgitation)
Only one valve implanted in the proper anatomical location</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Number of days from admission to discharge</time_frame>
    <description>Defined as device success and absence of in-hospital MACCE.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prosthetic Valve Dysfunction (PVD)</measure>
    <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
    <description>PVD was defined according to VARC using the site reported echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total AR reported as moderate or severe was considered PVD. AS was defined as significant stenosis and considered PVD if one of the following was met:
Peak velocity &gt;4 m/s
Mean gradient &gt;35 mmHg
EOA &lt; 0.8 cm2
TVIV1 / TVIV2 &lt; 0.25</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">2777</enrollment>
  <condition>Severe Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Extreme Risk: TAVI Iliofemoral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Extreme Risk: TAVI Non-Iliofemoral</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Risk: TAVI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</intervention_name>
    <arm_group_label>Extreme Risk: TAVI Iliofemoral</arm_group_label>
    <arm_group_label>Extreme Risk: TAVI Non-Iliofemoral</arm_group_label>
    <arm_group_label>High Risk: TAVI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. High Risk: Subject must have co-morbidities such that one cardiologist and two cardiac
             surgeons agree that predicted risk of operative mortality is ≥15% (and predicted
             operative mortality or serious, irreversible morbidity risk of &lt; 50%) at 30 days.

             OR

             Extreme Risk: Subject must have co-morbidities such that one cardiologist and two
             cardiac surgeons agree that medical factors preclude operation, based on a conclusion
             that the probability of death or serious morbidity exceeds the probability of
             meaningful improvement. Specifically, the predicted operative risk of death or
             serious, irreversible morbidity is ≥ 50% at 30 days.

          2. Subject has senile degenerative aortic valve stenosis with:

               -  Mean gradient &gt; 40 mmHg, or jet velocity greater than 4.0 m/sec by either resting
                  or dobutamine stress echocardiogram, or simultaneous pressure recordings at
                  cardiac catheterization (either resting or dobutamine stress), AND

               -  An initial aortic valve area of ≤ 0.8 cm2 (or aortic valve area index ≤ 0.5
                  cm2/m2) by resting echocardiogram or simultaneous pressure recordings at cardiac
                  catheterization

          3. Subject is symptomatic from his/her aortic valve stenosis, as demonstrated by New York
             Heart Association (NYHA) Functional Class II or greater.

          4. The subject or the subject's legal representative has been informed of the nature of
             the trial, agrees to its provisions and has provided written informed consent as
             approved by the IRB of the respective clinical site.

          5. The subject and the treating physician agree that the subject will return for all
             required post-procedure follow-up visits.

        Exclusion Criteria:

        Clinical

          1. Evidence of an acute myocardial infarction ≤ 30 days before the intended treatment.

          2. Any percutaneous coronary or peripheral interventional procedure performed within 30
             days prior to the MCS TAVI procedure including bare metal and drug eluting stents.

          3. Blood dyscrasias as defined: leukopenia (WBC &lt; 1000mm3), thrombocytopenia (platelet
             count &lt;50,000 cells/mm3), history of bleeding diathesis or coagulopathy.

          4. Untreated clinically significant coronary artery disease requiring revascularization.

          5. Cardiogenic shock manifested by low cardiac output, vasopressor dependence, or
             mechanical hemodynamic support.

          6. Need for emergency surgery for any reason.

          7. Severe ventricular dysfunction with left ventricular ejection fraction (LVEF) &lt; 20% as
             measured by resting echocardiogram.

          8. Recent (within 6 months) cerebrovascular accident (CVA) or transient ischemic attack
             (TIA).

          9. End stage renal disease requiring chronic dialysis or creatinine clearance &lt; 20
             cc/min.

         10. Active GI bleeding that would preclude anticoagulation.

         11. A known hypersensitivity or contraindication to any of the following which cannot be
             adequately pre-medicated:

               -  Aspirin

               -  Heparin (HIT/HITTS) and bivalirudin

               -  Nitinol (titanium or nickel)

               -  Ticlopidine and clopidogrel

               -  Contrast media

         12. Ongoing sepsis, including active endocarditis.

         13. Subject refuses a blood transfusion.

         14. Life expectancy &lt; 12 months due to associated non-cardiac co-morbid conditions.

         15. Other medical, social, or psychological conditions that in the opinion of an
             Investigator precludes the subject from appropriate consent.

         16. Severe dementia (resulting in either inability to provide informed consent for the
             trial/procedure, prevents independent lifestyle outside of a chronic care facility, or
             will fundamentally complicate rehabilitation from the procedure or compliance with
             follow-up visits).

         17. Currently participating in an investigational drug or another device trial.

         18. Symptomatic carotid or vertebral artery disease.

             Anatomical

         19. High Risk:Native aortic annulus size &lt; 20 mm or &gt; 29 mm per the baseline diagnostic
             imaging (until 23mm valve enrollment completion/closure in the CoreValve® US Pivotal
             Trial-High Risk Cohort)

             OR

             Extreme Risk: Native aortic annulus size &lt; 18 mm or &gt; 29 mm per the baseline
             diagnostic imaging. (High risk and extreme risk upon 23mm valve enrollment
             completion/closure in the CoreValve® US Pivotal Trial-High Risk Cohort)

         20. Pre-existing prosthetic heart valve any position.

         21. Mixed aortic valve disease (aortic stenosis and aortic regurgitation with predominant
             aortic regurgitation (3-4+)).

         22. Moderate to severe (3-4+) or severe (4+) mitral or severe (4+) tricuspid
             regurgitation.

         23. Moderate to severe mitral stenosis.

         24. Hypertrophic obstructive cardiomyopathy.

         25. Echocardiographic evidence of new or untreated intracardiac mass, thrombus or
             vegetation.

         26. Severe basal septal hypertrophy with an outflow gradient.

         27. Aortic root angulation (angle between plane of aortic valve annulus and horizontal
             plane/vertebrae) &gt; 70° (for femoral and left subclavian/axillary access) and &gt; 30°
             (for right subclavian/axillary access).

         28. Ascending aorta diameter &gt;43 mm if the aortic annulus diameter is 23-29 mm; ascending
             aortic diameter &gt; 40 mm if the aortic annulus diameter is 20-23 mm; or an ascending
             aorta diameter &gt; 34 mm if the aortic annulus diameter is 18-20 mm (Extreme Risk only
             until 23 mm valve enrollment completion/closure in the CoreValve® US Pivotal
             Trial-High Risk Cohort).

         29. Congenital bicuspid or unicuspid valve verified by echocardiography.

         30. Sinus of valsalva anatomy that would prevent adequate coronary perfusion.

             Vascular

         31. Transarterial access not able to accommodate an 18Fr sheath.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey J Popma, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David H Adams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Banner Good Samaritan</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southern California University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente - Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90072</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Palo Alto Health Care System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Hospital Center / Georgetown Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami Health System / Jackson Memorial Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Joseph's Hospital of Atlanta</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Center of Indiana</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South/Terrebonne General</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health Systems</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Detroit Medical Center Cardiovascular Institute</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John Hospital and Medical Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spectrum Health Hospitals</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Morristown Memorial Hospital</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07962</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital/ Long Island Jewish Hospital</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Francis Hospital</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University - Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals - Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Medical Center - The Richard M. Ross Heart Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Riverside Methodist Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <zip>17822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Heart and Vascular Hospital</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Heart Institute at St. Luke's Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Methodist Hospital - The Methodist DeBakey Heart &amp; Vascular Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fletcher Allen Healthcare</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inova Fairfax Hospital</name>
      <address>
        <city>Falls Church</city>
        <state>Virginia</state>
        <zip>22042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Sacred Heart Medical Center</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center - Aurora Health Care</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2012</study_first_submitted>
  <study_first_submitted_qc>February 8, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 10, 2012</study_first_posted>
  <results_first_submitted>September 1, 2016</results_first_submitted>
  <results_first_submitted_qc>June 29, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 18, 2017</results_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Valvular Heart Disease</keyword>
  <keyword>Critical Aortic Stenosis</keyword>
  <keyword>Severe Aortic Stenosis</keyword>
  <keyword>Extreme Risk</keyword>
  <keyword>High Risk</keyword>
  <keyword>Aortic Valve Replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constriction, Pathologic</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between February 21, 2012 and April 15, 2014, 1658 subjects were enrolled in the Continued Access Extreme Risk Study at 45 centers in the US. Between October 19, 2012 and August 12, 2014, 1119 subjects were enrolled in the High Risk Study at the same 45 US centers.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Extreme Risk: Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="P2">
          <title>Extreme Risk: Non-Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="P3">
          <title>High Risk</title>
          <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1285"/>
                <participants group_id="P2" count="373"/>
                <participants group_id="P3" count="1119"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="921"/>
                <participants group_id="P2" count="231"/>
                <participants group_id="P3" count="836"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="364"/>
                <participants group_id="P2" count="142"/>
                <participants group_id="P3" count="283"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>A total of 1658 Extreme Risk subjects were enrolled; 1257 Iliofemoral and 367 Non-Iliofemoral had an attempted implant procedure. A total of 1119 High Risk subjects were enrolled; however, 1108 subjects had an attempted implant procedure. The baseline data presented are for subjects with an attempted implant.</population>
      <group_list>
        <group group_id="B1">
          <title>Extreme Risk: Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="B2">
          <title>Extreme Risk: Non-Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="B3">
          <title>High Risk</title>
          <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1257"/>
            <count group_id="B2" value="367"/>
            <count group_id="B3" value="1108"/>
            <count group_id="B4" value="2732"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.5" spread="8.1"/>
                    <measurement group_id="B2" value="81.9" spread="8.2"/>
                    <measurement group_id="B3" value="83.6" spread="7.1"/>
                    <measurement group_id="B4" value="83.3" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="568"/>
                    <measurement group_id="B2" value="185"/>
                    <measurement group_id="B3" value="456"/>
                    <measurement group_id="B4" value="1209"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="689"/>
                    <measurement group_id="B2" value="182"/>
                    <measurement group_id="B3" value="652"/>
                    <measurement group_id="B4" value="1523"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1206"/>
                    <measurement group_id="B2" value="360"/>
                    <measurement group_id="B3" value="1056"/>
                    <measurement group_id="B4" value="2622"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Surface Area</title>
          <description>Participant Population= Consisted of all subjects with an attempted implant procedure.</description>
          <units>m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.9" spread="0.3"/>
                    <measurement group_id="B2" value="1.8" spread="0.3"/>
                    <measurement group_id="B3" value="1.9" spread="0.2"/>
                    <measurement group_id="B4" value="1.9" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association (NYHA) Classification</title>
          <description>NYHA Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>NYHA Classification I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA Classification II</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="159"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="180"/>
                    <measurement group_id="B4" value="384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA Classification III</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="881"/>
                    <measurement group_id="B2" value="248"/>
                    <measurement group_id="B3" value="811"/>
                    <measurement group_id="B4" value="1940"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>NYHA Classification IV</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="217"/>
                    <measurement group_id="B2" value="74"/>
                    <measurement group_id="B3" value="117"/>
                    <measurement group_id="B4" value="408"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Society of Thoracic Surgeons (STS) Risk Score</title>
          <description>The Society of Thoracic Surgeons (STS) risk model predicts the risk of operative mortality and morbidity after adult cardiac surgery on the basis of patient demographic and clinical variables. After information has been entered on a given case, the online STS risk calculator provides a risk percentage for each of the outcomes. The risk percentage estimates the chance of a specific outcome for a patient with the indicated risk factors. A higher score indicates a higher risk. A lower score indicates a lower risk.</description>
          <units>Percent of predicted mortality</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.1" spread="5.1"/>
                    <measurement group_id="B2" value="10.2" spread="5.6"/>
                    <measurement group_id="B3" value="7.7" spread="3.3"/>
                    <measurement group_id="B4" value="8.7" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Logistic European System for Cardiac Operative Risk Evaluation (EuroSCORE)</title>
          <description>The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a method of calculating predicted operative mortality for patients undergoing cardiac surgery. If a risk factor is present, a weight/number is assigned. The weights are added to give an approximate percent of predicted mortality. A higher score indicates a higher risk. A lower score indicates a lower risk.</description>
          <units>Percent of predicted mortality</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.2" spread="17.1"/>
                    <measurement group_id="B2" value="24.2" spread="17.1"/>
                    <measurement group_id="B3" value="20.3" spread="13.5"/>
                    <measurement group_id="B4" value="22.6" spread="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality</title>
        <description>All-cause Death or Major Stroke (Extreme Risk- Medtronic CoreValve® System); All-cause Mortality (High Risk Surgical- Medtronic CoreValve® System vs. Surgical Valve)</description>
        <time_frame>1 year</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Extreme Risk: All-cause Death or Major Stroke; High Risk Surgical: All-cause Mortality</title>
          <description>All-cause Death or Major Stroke (Extreme Risk- Medtronic CoreValve® System); All-cause Mortality (High Risk Surgical- Medtronic CoreValve® System vs. Surgical Valve)</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5"/>
                    <measurement group_id="O2" value="30.8"/>
                    <measurement group_id="O3" value="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)</title>
        <description>MACCE is defined as a composite of:
All-Cause Death
Myocardial Infarction (MI)
All Stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)</title>
          <description>MACCE is defined as a composite of:
All-Cause Death
Myocardial Infarction (MI)
All Stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1"/>
                    <measurement group_id="O2" value="16.1"/>
                    <measurement group_id="O3" value="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.2"/>
                    <measurement group_id="O2" value="28.4"/>
                    <measurement group_id="O3" value="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.6"/>
                    <measurement group_id="O2" value="36.2"/>
                    <measurement group_id="O3" value="24.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Occurrence of Individual MACCE Components</title>
        <description>Individual MACCE Components Include:
All Cause Mortality
MI
All stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>The Occurrence of Individual MACCE Components</title>
          <description>Individual MACCE Components Include:
All Cause Mortality
MI
All stroke
Reintervention (defined as any cardiac surgery or percutaneous reintervention catheter procedure that repairs, otherwise alters or adjusts, or replaces a previously implanted valve)</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5"/>
                    <measurement group_id="O2" value="9.6"/>
                    <measurement group_id="O3" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1"/>
                    <measurement group_id="O2" value="1.4"/>
                    <measurement group_id="O3" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6"/>
                    <measurement group_id="O2" value="5.9"/>
                    <measurement group_id="O3" value="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6"/>
                    <measurement group_id="O2" value="0.8"/>
                    <measurement group_id="O3" value="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7"/>
                    <measurement group_id="O2" value="20.8"/>
                    <measurement group_id="O3" value="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.6"/>
                    <measurement group_id="O2" value="2.7"/>
                    <measurement group_id="O3" value="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6"/>
                    <measurement group_id="O2" value="8.2"/>
                    <measurement group_id="O3" value="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9"/>
                    <measurement group_id="O2" value="0.8"/>
                    <measurement group_id="O3" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year All Cause Mortality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.0"/>
                    <measurement group_id="O2" value="29.4"/>
                    <measurement group_id="O3" value="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year MI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                    <measurement group_id="O2" value="3.8"/>
                    <measurement group_id="O3" value="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3"/>
                    <measurement group_id="O2" value="9.2"/>
                    <measurement group_id="O3" value="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Reintervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0"/>
                    <measurement group_id="O2" value="1.2"/>
                    <measurement group_id="O3" value="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Adverse Events (MAEs)</title>
        <description>MAEs Include:
MACCE
Acute Kidney Injury
Cardiac Tamponade
Prosthetic Valve Dysfunction
Cardiogenic Shock
Valve Endocarditis
Life-Threatening, Disabling or Major Bleeding
Major Vascular Complication
Cardiac Perforation
Device Migration/Valve Embolism</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Events (MAEs)</title>
          <description>MAEs Include:
MACCE
Acute Kidney Injury
Cardiac Tamponade
Prosthetic Valve Dysfunction
Cardiogenic Shock
Valve Endocarditis
Life-Threatening, Disabling or Major Bleeding
Major Vascular Complication
Cardiac Perforation
Device Migration/Valve Embolism</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.3"/>
                    <measurement group_id="O2" value="67.4"/>
                    <measurement group_id="O3" value="48.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.0"/>
                    <measurement group_id="O2" value="73.1"/>
                    <measurement group_id="O3" value="54.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.7"/>
                    <measurement group_id="O2" value="76.4"/>
                    <measurement group_id="O3" value="59.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Conduction Disturbance Requiring Permanent Pacemaker Implantation</title>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Conduction Disturbance Requiring Permanent Pacemaker Implantation</title>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.2"/>
                    <measurement group_id="O2" value="23.0"/>
                    <measurement group_id="O3" value="28.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.7"/>
                    <measurement group_id="O2" value="24.6"/>
                    <measurement group_id="O3" value="30.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.1"/>
                    <measurement group_id="O2" value="25.5"/>
                    <measurement group_id="O3" value="32.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in NYHA Class</title>
        <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
NYHA Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
        <time_frame>Baseline to 30 days, baseline to 6 months, baseline to 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in NYHA Class</title>
          <description>Change from baseline (continuous variable). A positive number corresponds to NYHA worsening; a negative number corresponds to NYHA improvement.
NYHA Classification:
Class I: Subjects with cardiac disease but without resulting limitations of physical activity.
Class I: Subjects with cardiac disease resulting in slight limitation of physical activity.
Class III: Subjects with cardiac disease resulting in marked limitation of physical activity.
Class IV: Subjects with cardiac disease resulting in inability to carry on any physical activity without discomfort.</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>average classification level change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.2" spread="0.8"/>
                    <measurement group_id="O2" value="-1.1" spread="0.9"/>
                    <measurement group_id="O3" value="-1.2" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.8"/>
                    <measurement group_id="O2" value="-1.4" spread="0.8"/>
                    <measurement group_id="O3" value="-1.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.4" spread="0.8"/>
                    <measurement group_id="O2" value="-1.4" spread="0.9"/>
                    <measurement group_id="O3" value="-1.4" spread="0.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Distance Walked During 6-Minute Walk Test (6MWT)</title>
        <description>Change in distance walked during 6MWT from baseline</description>
        <time_frame>Baseline to 30 days, baseline to 1 year</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Distance Walked During 6-Minute Walk Test (6MWT)</title>
          <description>Change in distance walked during 6MWT from baseline</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline to 30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.3" spread="116.4"/>
                    <measurement group_id="O2" value="4.0" spread="110.4"/>
                    <measurement group_id="O3" value="38.1" spread="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline to 1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.8" spread="121.2"/>
                    <measurement group_id="O2" value="28.5" spread="137.4"/>
                    <measurement group_id="O3" value="55.5" spread="117.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ratio of Days Alive Out of Hospital at 365 Days Post Procedure Versus Total Days Alive</title>
        <time_frame>1 year</time_frame>
        <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio of Days Alive Out of Hospital at 365 Days Post Procedure Versus Total Days Alive</title>
          <population>Participant Population= Consisted of all subjects with an attempted implant procedure.</population>
          <units>ratio of days alive and out of hospital</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="0.3"/>
                    <measurement group_id="O2" value="0.7" spread="0.4"/>
                    <measurement group_id="O3" value="0.8" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life (QoL) Change</title>
        <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
12 Item Short Form Health Survey (SF-12): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
        <time_frame>30 day, 6 month, 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life (QoL) Change</title>
          <description>QoL summary score change from baseline using the following measures:
Kansas City Cardiomyopathy Questionnaire (KCCQ): Quantifies physical function, symptoms, social function, self-efficacy and knowledge, and quality of life. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
12 Item Short Form Health Survey (SF-12): Measures functional health and well-being. Scores are transformed to a range of 0-100, in which higher scores reflect better health status.
European QoL (EQ-5D): Measures 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) that can be converted to utilities using an algorithm. Utilities range from 0 to 1, with 1 representing perfect health, and 0 corresponding to the worst imaginable health state.</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.3" spread="26.4"/>
                    <measurement group_id="O2" value="19.9" spread="29.8"/>
                    <measurement group_id="O3" value="19.9" spread="25.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.7" spread="26.6"/>
                    <measurement group_id="O2" value="16.5" spread="30.2"/>
                    <measurement group_id="O3" value="16.6" spread="24.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day SF-12-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" spread="10.7"/>
                    <measurement group_id="O2" value="5.1" spread="10.7"/>
                    <measurement group_id="O3" value="5.7" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day SF-12-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="13.9"/>
                    <measurement group_id="O2" value="4.5" spread="14.5"/>
                    <measurement group_id="O3" value="3.0" spread="12.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.26"/>
                    <measurement group_id="O2" value="0.07" spread="0.30"/>
                    <measurement group_id="O3" value="0.05" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.7" spread="27.3"/>
                    <measurement group_id="O2" value="29.6" spread="28.5"/>
                    <measurement group_id="O3" value="26.2" spread="25.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.8" spread="27.7"/>
                    <measurement group_id="O2" value="23.2" spread="28.5"/>
                    <measurement group_id="O3" value="20.8" spread="24.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month SF-12-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" spread="11.1"/>
                    <measurement group_id="O2" value="6.8" spread="11.4"/>
                    <measurement group_id="O3" value="7.1" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month SF-12-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9" spread="13.9"/>
                    <measurement group_id="O2" value="7.9" spread="14.9"/>
                    <measurement group_id="O3" value="4.4" spread="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.25"/>
                    <measurement group_id="O2" value="0.11" spread="0.27"/>
                    <measurement group_id="O3" value="0.06" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year KCCQ- Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.0" spread="27.5"/>
                    <measurement group_id="O2" value="28.7" spread="27.5"/>
                    <measurement group_id="O3" value="27.1" spread="24.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year KCCQ- Clinical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.8" spread="27.9"/>
                    <measurement group_id="O2" value="21.7" spread="27.2"/>
                    <measurement group_id="O3" value="21.0" spread="24.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year SF-12-Physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="11.7"/>
                    <measurement group_id="O2" value="6.4" spread="11.4"/>
                    <measurement group_id="O3" value="6.6" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year SF-12-Mental</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="13.9"/>
                    <measurement group_id="O2" value="6.4" spread="13.8"/>
                    <measurement group_id="O3" value="4.7" spread="12.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year EQ-5D</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" spread="0.26"/>
                    <measurement group_id="O2" value="0.08" spread="0.27"/>
                    <measurement group_id="O3" value="0.05" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiographic Assessment of Valve Performance</title>
        <description>Using the following measure:
• Effective Orifice Area (EOA) analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Implanted Cohort</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>High Risk: Implanted Cohort</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiographic Assessment of Valve Performance</title>
          <description>Using the following measure:
• Effective Orifice Area (EOA) analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
          <population>Participant Population = Consisted of all subjects with a valve implanted.</population>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1615"/>
                <count group_id="O2" value="1102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.77" spread="0.53"/>
                    <measurement group_id="O2" value="1.77" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.75" spread="0.54"/>
                    <measurement group_id="O2" value="1.78" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.78" spread="0.54"/>
                    <measurement group_id="O2" value="1.77" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiographic Assessment of Valve Performance</title>
        <description>Using the following measure:
• Transvalvular Mean Gradient analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Implanted Cohort</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>High Risk: Implanted Cohort</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiographic Assessment of Valve Performance</title>
          <description>Using the following measure:
• Transvalvular Mean Gradient analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
          <population>Participant Population= Consisted of all subjects with a valve implanted.</population>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1615"/>
                <count group_id="O2" value="1102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.20" spread="4.26"/>
                    <measurement group_id="O2" value="8.02" spread="3.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.98" spread="3.63"/>
                    <measurement group_id="O2" value="7.97" spread="3.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.72" spread="3.40"/>
                    <measurement group_id="O2" value="8.12" spread="3.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Echocardiographic Assessment of Valve Performance</title>
        <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular) analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Implanted Cohort</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>High Risk: Implanted Cohort</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Echocardiographic Assessment of Valve Performance</title>
          <description>Using the following measure:
- Degree of Aortic Valve Regurgitation (Transvalvular and Paravalvular) analyzed overall per Extreme Risk or High Risk. Iliofemoral access and non-iliofemoral access are not reported separate because this is a valve performance measurement.</description>
          <population>Participant Population = Consisted of all subjects with a valve implanted.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1615"/>
                <count group_id="O2" value="1102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.5"/>
                    <measurement group_id="O2" value="28.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.3"/>
                    <measurement group_id="O2" value="65.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.9"/>
                    <measurement group_id="O2" value="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3"/>
                    <measurement group_id="O2" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.1"/>
                    <measurement group_id="O2" value="37.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.5"/>
                    <measurement group_id="O2" value="58.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1"/>
                    <measurement group_id="O2" value="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                    <measurement group_id="O2" value="0.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- None</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="39.8"/>
                    <measurement group_id="O2" value="39.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Mild</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.9"/>
                    <measurement group_id="O2" value="56.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Moderate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1"/>
                    <measurement group_id="O2" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Total Aortic Regurgitation- Severe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.2"/>
                    <measurement group_id="O2" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Aortic Valve Hospitalizations</title>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Aortic Valve Hospitalizations</title>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.2"/>
                    <measurement group_id="O2" value="5.5"/>
                    <measurement group_id="O3" value="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5"/>
                    <measurement group_id="O2" value="12.9"/>
                    <measurement group_id="O3" value="11.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.1"/>
                    <measurement group_id="O2" value="16.5"/>
                    <measurement group_id="O3" value="15.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Deaths and Valve-Related Deaths</title>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Deaths and Valve-Related Deaths</title>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4"/>
                    <measurement group_id="O2" value="9.3"/>
                    <measurement group_id="O3" value="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9"/>
                    <measurement group_id="O2" value="4.2"/>
                    <measurement group_id="O3" value="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3"/>
                    <measurement group_id="O2" value="16.3"/>
                    <measurement group_id="O3" value="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9"/>
                    <measurement group_id="O2" value="5.7"/>
                    <measurement group_id="O3" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Cardiovascular Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.6"/>
                    <measurement group_id="O2" value="22.0"/>
                    <measurement group_id="O3" value="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Valve Related Deaths</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5"/>
                    <measurement group_id="O2" value="6.4"/>
                    <measurement group_id="O3" value="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Strokes and Transient Ischemic Attacks (TIAs)</title>
        <description>Strokes (of any severity) and TIAs</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Strokes and Transient Ischemic Attacks (TIAs)</title>
          <description>Strokes (of any severity) and TIAs</description>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants, Kaplan-Meier</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.6"/>
                    <measurement group_id="O2" value="5.9"/>
                    <measurement group_id="O3" value="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day TIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.7"/>
                    <measurement group_id="O2" value="0.3"/>
                    <measurement group_id="O3" value="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6"/>
                    <measurement group_id="O2" value="8.2"/>
                    <measurement group_id="O3" value="6.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month TIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.4"/>
                    <measurement group_id="O2" value="0.9"/>
                    <measurement group_id="O3" value="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.3"/>
                    <measurement group_id="O2" value="9.2"/>
                    <measurement group_id="O3" value="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year TIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0"/>
                    <measurement group_id="O2" value="0.9"/>
                    <measurement group_id="O3" value="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Index Procedure Related MAEs</title>
        <time_frame>Procedure</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Index Procedure Related MAEs</title>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.4"/>
                    <measurement group_id="O2" value="66.6"/>
                    <measurement group_id="O3" value="48.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Index Procedure Hospital Stay</title>
        <time_frame>Number of days from admission to discharge</time_frame>
        <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Index Procedure Hospital Stay</title>
          <population>Participant Population = Consisted of all subjects with an attempted implant procedure.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1257"/>
                <count group_id="O2" value="367"/>
                <count group_id="O3" value="1108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.6" spread="6.9"/>
                    <measurement group_id="O2" value="10.7" spread="8.7"/>
                    <measurement group_id="O3" value="7.6" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Success</title>
        <description>Defined as:
Successful vascular access, delivery and deployment of the device, and successful retrieval of the delivery system,
Correct position of the device in the proper anatomical location (placement in the annulus with no impedance on device function),
Intended performance of the prosthetic valve (aortic valve area &gt; 1.2 cm2 for 26, 29 and 31mm valves, ≥ 0.9 cm2 for 23mm valve (by echocardiography using the continuity equation) and mean aortic valve gradient &lt; 20 mmHg or peak velocity &lt; 3 m/sec, without moderate or severe prosthetic valve aortic regurgitation)
Only one valve implanted in the proper anatomical location</description>
        <time_frame>Number of days from admission to discharge</time_frame>
        <population>Participant Population= Consisted of all subjects with a TAVR index procedure who were evaluable for device success.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Device Success</title>
          <description>Defined as:
Successful vascular access, delivery and deployment of the device, and successful retrieval of the delivery system,
Correct position of the device in the proper anatomical location (placement in the annulus with no impedance on device function),
Intended performance of the prosthetic valve (aortic valve area &gt; 1.2 cm2 for 26, 29 and 31mm valves, ≥ 0.9 cm2 for 23mm valve (by echocardiography using the continuity equation) and mean aortic valve gradient &lt; 20 mmHg or peak velocity &lt; 3 m/sec, without moderate or severe prosthetic valve aortic regurgitation)
Only one valve implanted in the proper anatomical location</description>
          <population>Participant Population= Consisted of all subjects with a TAVR index procedure who were evaluable for device success.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1252"/>
                <count group_id="O2" value="365"/>
                <count group_id="O3" value="1104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.9"/>
                    <measurement group_id="O2" value="88.1"/>
                    <measurement group_id="O3" value="87.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success</title>
        <description>Defined as device success and absence of in-hospital MACCE.</description>
        <time_frame>Number of days from admission to discharge</time_frame>
        <population>Participant Population = Consisted of all subjects with an index procedure who were evaluable for procedural success.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Procedural Success</title>
          <description>Defined as device success and absence of in-hospital MACCE.</description>
          <population>Participant Population = Consisted of all subjects with an index procedure who were evaluable for procedural success.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1252"/>
                <count group_id="O2" value="365"/>
                <count group_id="O3" value="1104"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.7"/>
                    <measurement group_id="O2" value="76.8"/>
                    <measurement group_id="O3" value="82.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prosthetic Valve Dysfunction (PVD)</title>
        <description>PVD was defined according to VARC using the site reported echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total AR reported as moderate or severe was considered PVD. AS was defined as significant stenosis and considered PVD if one of the following was met:
Peak velocity &gt;4 m/s
Mean gradient &gt;35 mmHg
EOA &lt; 0.8 cm2
TVIV1 / TVIV2 &lt; 0.25</description>
        <time_frame>30 day, 6 months, and 1 year. The 2-5 year outcome data will be reported once data set is complete.</time_frame>
        <population>Participant Population = Consisted of all subjects with a valve implanted.</population>
        <group_list>
          <group group_id="O1">
            <title>Extreme Risk: Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O2">
            <title>Extreme Risk: Non-Iliofemoral</title>
            <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
          <group group_id="O3">
            <title>High Risk</title>
            <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
          </group>
        </group_list>
        <measure>
          <title>Prosthetic Valve Dysfunction (PVD)</title>
          <description>PVD was defined according to VARC using the site reported echocardiography assessments including aortic regurgitation (AR) and aortic stenosis (AS) evaluations. Total AR reported as moderate or severe was considered PVD. AS was defined as significant stenosis and considered PVD if one of the following was met:
Peak velocity &gt;4 m/s
Mean gradient &gt;35 mmHg
EOA &lt; 0.8 cm2
TVIV1 / TVIV2 &lt; 0.25</description>
          <population>Participant Population = Consisted of all subjects with a valve implanted.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1251"/>
                <count group_id="O2" value="364"/>
                <count group_id="O3" value="1102"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 day Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0"/>
                    <measurement group_id="O2" value="0.8"/>
                    <measurement group_id="O3" value="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 day Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0"/>
                    <measurement group_id="O2" value="1.9"/>
                    <measurement group_id="O3" value="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                    <measurement group_id="O2" value="0.8"/>
                    <measurement group_id="O3" value="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0"/>
                    <measurement group_id="O2" value="3.3"/>
                    <measurement group_id="O3" value="3.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Aortic Stenosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8"/>
                    <measurement group_id="O2" value="1.6"/>
                    <measurement group_id="O3" value="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 year Aortic Regurgitation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8"/>
                    <measurement group_id="O2" value="3.8"/>
                    <measurement group_id="O3" value="4.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events (AEs) were collected from study enrollment to study closure, up to 5 years.</time_frame>
      <desc>All new or worsening AEs were collected through1 year. After 1 year, serious AEs, major AEs, cardiovascular events, device-related AEs, device related technical observations, unanticipated adverse device effects, strokes, and deaths were collected. AE data reported are Clinical Event Committee adjudicated AEs for subjects with an attempted implant.</desc>
      <group_list>
        <group group_id="E1">
          <title>Extreme Risk: TAVI Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="E2">
          <title>Extreme Risk: TAVI Non-Iliofemoral</title>
          <description>Extreme Risk Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI); Non-Iliofemoral Access
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
        <group group_id="E3">
          <title>High Risk: TAVI</title>
          <description>High Risk Surgical Patients: Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)
Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 14.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1117" subjects_at_risk="1257"/>
                <counts group_id="E2" subjects_affected="359" subjects_at_risk="367"/>
                <counts group_id="E3" subjects_affected="1004" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia Deficiencies</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Anaemias Due To Chronic Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Anaemias</sub_title>
                <counts group_id="E1" events="420" subjects_affected="340" subjects_at_risk="1257"/>
                <counts group_id="E2" events="182" subjects_affected="150" subjects_at_risk="367"/>
                <counts group_id="E3" events="319" subjects_affected="265" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Coagulopathies</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Haemolyses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Leukocytoses</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lymphatic System Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Marrow Depression And Hypoplastic Anaemias</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Spleen Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thrombocytopenias</sub_title>
                <counts group_id="E1" events="34" subjects_affected="34" subjects_at_risk="1257"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="367"/>
                <counts group_id="E3" events="21" subjects_affected="20" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic Valvular Disorders</sub_title>
                <counts group_id="E1" events="153" subjects_affected="143" subjects_at_risk="1257"/>
                <counts group_id="E2" events="29" subjects_affected="26" subjects_at_risk="367"/>
                <counts group_id="E3" events="108" subjects_affected="103" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Conduction Disorders</sub_title>
                <counts group_id="E1" events="311" subjects_affected="293" subjects_at_risk="1257"/>
                <counts group_id="E2" events="66" subjects_affected="63" subjects_at_risk="367"/>
                <counts group_id="E3" events="296" subjects_affected="277" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Disorders</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiomyopathies</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disorders</sub_title>
                <counts group_id="E1" events="28" subjects_affected="26" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Heart Failures</sub_title>
                <counts group_id="E1" events="531" subjects_affected="329" subjects_at_risk="1257"/>
                <counts group_id="E2" events="147" subjects_affected="105" subjects_at_risk="367"/>
                <counts group_id="E3" events="346" subjects_affected="248" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ischaemic Coronary Artery Disorders</sub_title>
                <counts group_id="E1" events="102" subjects_affected="91" subjects_at_risk="1257"/>
                <counts group_id="E2" events="30" subjects_affected="26" subjects_at_risk="367"/>
                <counts group_id="E3" events="97" subjects_affected="78" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mitral Valvular Disorders</sub_title>
                <counts group_id="E1" events="37" subjects_affected="36" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="30" subjects_affected="28" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Myocardial Disorders</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pericardial Disorders</sub_title>
                <counts group_id="E1" events="24" subjects_affected="22" subjects_at_risk="1257"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="33" subjects_affected="30" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pulmonary Valvular Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Rate And Rhythm Disorders</sub_title>
                <counts group_id="E1" events="77" subjects_affected="75" subjects_at_risk="1257"/>
                <counts group_id="E2" events="21" subjects_affected="20" subjects_at_risk="367"/>
                <counts group_id="E3" events="54" subjects_affected="50" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failures</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Supraventricular Arrhythmias</sub_title>
                <counts group_id="E1" events="184" subjects_affected="152" subjects_at_risk="1257"/>
                <counts group_id="E2" events="55" subjects_affected="47" subjects_at_risk="367"/>
                <counts group_id="E3" events="137" subjects_affected="119" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Tricuspid Valvular Disorders</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmias And Cardiac Arrest</sub_title>
                <counts group_id="E1" events="150" subjects_affected="139" subjects_at_risk="1257"/>
                <counts group_id="E2" events="49" subjects_affected="43" subjects_at_risk="367"/>
                <counts group_id="E3" events="113" subjects_affected="104" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Malpositions Congenital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Septal Defects Congenital</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiovascular Disorders Congenital</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Male Reproductive Tract Disorders Congenital</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Anomalies Congenital</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Eustachian Tube Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>External Ear Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Inner Ear Signs And Symptoms</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Middle Ear Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroid Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thyroid Hyperfunction Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thyroid Hypofunction Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness (Excl Colour Blindness)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cataract Conditions</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Conjunctival And Corneal Bleeding And Vascular Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Corneal Structural Change, Deposit And Degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lens Structural Change, Deposit And Degeneration (Excl Cataracts)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lid, Lash And Lacrimal Structural Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ocular Bleeding And Vascular Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Partial Vision Loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Retinal Bleeding And Vascular Disorders (Excl Retinopathy)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Retinal Structural Change, Deposit And Degeneration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Retinal, Choroid And Vitreous Infections And Inflammations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Visual Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Findings Abnormal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Abdominal Hernias, Site Unspecified</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Abdominal Wall Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Acute And Chronic Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Anal And Rectal Pains</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Benign Neoplasms Gastrointestinal (Excl Oral Cavity)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Colitis (Excl Infective)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dental And Periodontal Infections And Inflammations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dental Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Hernias</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Diarrhoea (Excl Infective)</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Diverticula</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Duodenal And Small Intestinal Stenosis And Obstruction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dyspeptic Signs And Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Faecal Abnormalities</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Flatulence, Bloating And Distension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastric And Oesophageal Haemorrhages</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastric Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastritis (Excl Infective)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal And Abdominal Pains (Excl Oral And Throat)</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Atonic And Hypomotility Disorders</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Dyskinetic Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Fistulae</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Inflammatory Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Necrosis And Gangrene (Excl Gangrenous Hernia)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Signs And Symptoms</sub_title>
                <counts group_id="E1" events="35" subjects_affected="35" subjects_at_risk="1257"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="367"/>
                <counts group_id="E3" events="17" subjects_affected="16" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Stenosis And Obstruction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Ulcers And Perforation, Site Unspecified</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Vascular Occlusion And Infarction</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gingival Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Haemorrhoids And Gastrointestinal Varices (Excl Oesophageal)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Inguinal Hernias</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Intestinal Haemorrhages</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Intestinal Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Large Intestinal Stenosis And Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nausea And Vomiting Symptoms</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Gastrointestinal Haemorrhages</sub_title>
                <counts group_id="E1" events="121" subjects_affected="98" subjects_at_risk="1257"/>
                <counts group_id="E2" events="35" subjects_affected="26" subjects_at_risk="367"/>
                <counts group_id="E3" events="84" subjects_affected="71" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oesophageal Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oesophageal Stenosis And Obstruction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oesophageal Ulcers And Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oesophagitis (Excl Infective)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peritoneal And Retroperitoneal Disorders</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peritoneal And Retroperitoneal Haemorrhages</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Tongue Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Umbilical Hernias</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Administration Site Reactions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Asthenic Conditions</sub_title>
                <counts group_id="E1" events="33" subjects_affected="31" subjects_at_risk="1257"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="25" subjects_affected="23" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Body Temperature Altered</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Complications Associated With Device</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Death And Sudden Death</sub_title>
                <counts group_id="E1" events="49" subjects_affected="49" subjects_at_risk="1257"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="367"/>
                <counts group_id="E3" events="38" subjects_affected="38" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Device Issues</sub_title>
                <counts group_id="E1" events="140" subjects_affected="130" subjects_at_risk="1257"/>
                <counts group_id="E2" events="19" subjects_affected="17" subjects_at_risk="367"/>
                <counts group_id="E3" events="103" subjects_affected="93" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Device Malfunction Events</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Device Physical Property And Chemical Issues</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Febrile Disorders</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gait Disturbances</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>General Signs And Symptoms</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Healing Abnormal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hernias</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Implant And Catheter Site Reactions</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Inflammations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Injection Site Reactions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mucosal Findings Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="32" subjects_affected="31" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="367"/>
                <counts group_id="E3" events="17" subjects_affected="15" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pain And Discomfort</sub_title>
                <counts group_id="E1" events="85" subjects_affected="67" subjects_at_risk="1257"/>
                <counts group_id="E2" events="18" subjects_affected="14" subjects_at_risk="367"/>
                <counts group_id="E3" events="41" subjects_affected="40" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Product Physical Issues</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Therapeutic And Nontherapeutic Responses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ulcers</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Complications Associated With Device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile Duct Infections And Inflammations</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cholecystitis And Cholelithiasis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cholestasis And Jaundice</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gallbladder Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatic And Hepatobiliary Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatic Failure And Associated Disorders</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatic Fibrosis And Cirrhosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatic Vascular Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatobiliary Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatocellular Damage And Hepatitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Obstructive Bile Duct Disorders (Excl Neoplasms)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Acute And Chronic Sarcoidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Allergic Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Allergies To Foods, Food Additives, Drugs And Other Chemicals</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal And Gastrointestinal Infections</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Aspergillus Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Atypical Mycobacterial Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bacterial Infections</sub_title>
                <counts group_id="E1" events="66" subjects_affected="54" subjects_at_risk="1257"/>
                <counts group_id="E2" events="22" subjects_affected="17" subjects_at_risk="367"/>
                <counts group_id="E3" events="42" subjects_affected="37" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bone And Joint Infections</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Candida Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Infections</sub_title>
                <counts group_id="E1" events="16" subjects_affected="15" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Clostridia Infections</sub_title>
                <counts group_id="E1" events="23" subjects_affected="19" subjects_at_risk="1257"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dental And Oral Soft Tissue Infections</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ear Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Enterobacter Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Enterococcal Infections</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Escherichia Infections</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Eye And Eyelid Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Fungal Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Haemophilus Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Helicobacter Infections</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatobiliary And Spleen Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Herpes Viral Infections</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Infections</sub_title>
                <counts group_id="E1" events="30" subjects_affected="28" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="22" subjects_affected="20" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Infectious Disorders Carrier</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Infectious Transmissions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Influenza Viral Infections</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="12" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Klebsiella Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract And Lung Infections</sub_title>
                <counts group_id="E1" events="218" subjects_affected="170" subjects_at_risk="1257"/>
                <counts group_id="E2" events="73" subjects_affected="61" subjects_at_risk="367"/>
                <counts group_id="E3" events="116" subjects_affected="101" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Male Reproductive Tract Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pseudomonal Infections</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory Syncytial Viral Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Salmonella Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Sepsis, Bacteraemia, Viraemia And Fungaemia</sub_title>
                <counts group_id="E1" events="133" subjects_affected="113" subjects_at_risk="1257"/>
                <counts group_id="E2" events="37" subjects_affected="35" subjects_at_risk="367"/>
                <counts group_id="E3" events="87" subjects_affected="82" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Structures And Soft Tissue Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infections</sub_title>
                <counts group_id="E1" events="17" subjects_affected="15" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Streptococcal Infections</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infections</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infections</sub_title>
                <counts group_id="E1" events="132" subjects_affected="112" subjects_at_risk="1257"/>
                <counts group_id="E2" events="32" subjects_affected="25" subjects_at_risk="367"/>
                <counts group_id="E3" events="67" subjects_affected="58" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Infections</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Viral Infections</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal Injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac And Vascular Procedural Complications</sub_title>
                <counts group_id="E1" events="38" subjects_affected="37" subjects_at_risk="1257"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="367"/>
                <counts group_id="E3" events="27" subjects_affected="27" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiovascular Injuries</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cerebral Injuries</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Chest And Lung Injuries</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ear Injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Eye Injuries</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Gastrointestinal And Hepatobiliary Procedural Complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Limb Injuries (Incl Traumatic Amputation)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lower Limb Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="73" subjects_affected="69" subjects_at_risk="1257"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="367"/>
                <counts group_id="E3" events="28" subjects_affected="28" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Muscle, Tendon And Ligament Injuries</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nerve Injuries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Neurological And Psychiatric Procedural Complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Injuries</sub_title>
                <counts group_id="E1" events="67" subjects_affected="63" subjects_at_risk="1257"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="367"/>
                <counts group_id="E3" events="51" subjects_affected="48" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Procedural Complications</sub_title>
                <counts group_id="E1" events="82" subjects_affected="78" subjects_at_risk="1257"/>
                <counts group_id="E2" events="29" subjects_affected="25" subjects_at_risk="367"/>
                <counts group_id="E3" events="54" subjects_affected="52" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Overdoses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pelvic Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Poisoning And Toxicity</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal And Urinary Tract Injuries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory Tract And Thoracic Cavity Procedural Complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Site Specific Injuries</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Injuries</sub_title>
                <counts group_id="E1" events="24" subjects_affected="21" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="12" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skull Fractures, Facial Bone Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Spinal Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thermal Burns</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thoracic Cage Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Transfusion Related Complications</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Upper Limb Fractures And Dislocations</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="14" subjects_affected="12" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Tract Procedural Complications</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood Counts</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Blood Gas And Acid Base Analyses</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Carbohydrate Tolerance Analyses (Incl Diabetes)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Function Diagnostic Procedures</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="17" subjects_affected="17" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Coagulation And Bleeding Analyses</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="1257"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="17" subjects_affected="14" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ecg Investigations</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Faecal Analyses</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Heart Rate And Pulse Investigations</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatobiliary Histopathology Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Liver Function Analyses</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Metabolism Tests</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mineral And Electrolyte Analyses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Musculoskeletal And Soft Tissue Histopathology Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Physical Examination Procedures</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Platelet Analyses</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Protein Analyses</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Red Blood Cell Analyses</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Function Analyses</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory And Pulmonary Function Diagnostic Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory Tract And Thoracic Imaging Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skeletal And Cardiac Muscle Analyses</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinalysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Tract Function Analyses</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Auscultatory Investigations</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Tests (Incl Blood Pressure)</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>White Blood Cell Analyses</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Appetite Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Calcium Metabolism Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Chloride Imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus (Incl Subtypes)</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Diabetic Complications</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Disorders Of Purine Metabolism</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>General Nutritional Disorders</sub_title>
                <counts group_id="E1" events="32" subjects_affected="31" subjects_at_risk="1257"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="367"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic Conditions</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="15" subjects_affected="15" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Conditions</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="1257"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="367"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Magnesium Metabolism Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Metabolic Acidoses (Excl Diabetic Acidoses)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Metabolic Alkaloses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mixed Acid-Base Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Phosphorus Metabolism Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Potassium Imbalance</sub_title>
                <counts group_id="E1" events="37" subjects_affected="34" subjects_at_risk="1257"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="367"/>
                <counts group_id="E3" events="26" subjects_affected="25" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Protein Metabolism Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Sodium Imbalance</sub_title>
                <counts group_id="E1" events="23" subjects_affected="21" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="23" subjects_affected="20" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Total Fluid Volume Decreased</sub_title>
                <counts group_id="E1" events="37" subjects_affected="37" subjects_at_risk="1257"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="367"/>
                <counts group_id="E3" events="30" subjects_affected="29" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Total Fluid Volume Increased</sub_title>
                <counts group_id="E1" events="36" subjects_affected="35" subjects_at_risk="1257"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="367"/>
                <counts group_id="E3" events="23" subjects_affected="23" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthropathies</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bone Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bursal Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Connective Tissue Disorders (Excl Le)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Crystal Arthropathic Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Extremity Deformities</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Joint Related Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Joint Related Signs And Symptoms</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Muscle Infections And Inflammations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Muscle Pains</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Muscle Related Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Muscle Weakness Conditions</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Musculoskeletal And Connective Tissue Pain And Discomfort</sub_title>
                <counts group_id="E1" events="43" subjects_affected="38" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="25" subjects_affected="23" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Musculoskeletal And Connective Tissue Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Myopathies</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Osteoarthropathies</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="15" subjects_affected="13" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Rheumatoid Arthropathies</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Soft Tissue Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Spine And Neck Deformities</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Tendon Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>B-Cell Lymphomas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bile Duct Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bladder Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bone Neoplasms Malignant (Excl Sarcomas)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Breast And Nipple Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Burkitt's Lymphomas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiovascular Neoplasms Benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Central Nervous System Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Colonic Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hepatic Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Leiomyosarcomas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Leukaemias Acute Myeloid</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Leukaemias Chronic Lymphocytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Leukaemias</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lip And Oral Cavity Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lymphomas Unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mantle Cell Lymphomas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Metastases To Specified Sites</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Multiple Myelomas</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Myelodysplastic Syndromes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Myeloproliferative Disorders (Excl Leukaemias)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Neoplasms Malignant Site Unspecified</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nervous System Neoplasms Unspecified Malignancy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Neoplasms Malignant Of The Respiratory Tract Cell Type Specified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oesophageal Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oncologic Complications And Emergencies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pancreatic Neoplasms Malignant (Excl Islet Cell And Carcinoid)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Prostatic Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Rectal Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory Tract And Pleural Neoplasms Malignant Cell Type Unspecified</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Melanomas (Excl Ocular)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Neoplasms Benign</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Neoplasms Malignant And Unspecified (Excl Melanoma)</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Small Intestinal Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Soft Tissue Sarcomas Histology Unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thyroid Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Tract Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Uterine Neoplasms Benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Uterine Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vulval Neoplasms Malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Polyneuropathies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Alzheimer's Disease (Incl Subtypes)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Autonomic Nervous System Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Central Nervous System Aneurysms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Central Nervous System Haemorrhages And Cerebrovascular Accidents</sub_title>
                <counts group_id="E1" events="105" subjects_affected="98" subjects_at_risk="1257"/>
                <counts group_id="E2" events="33" subjects_affected="30" subjects_at_risk="367"/>
                <counts group_id="E3" events="86" subjects_affected="79" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Central Nervous System Vascular Disorders</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cerebellar Coordination And Balance Disturbances</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Coma States</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cortical Dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dementia (Excl Alzheimer's Type)</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Disturbances In Consciousness</sub_title>
                <counts group_id="E1" events="46" subjects_affected="42" subjects_at_risk="1257"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="367"/>
                <counts group_id="E3" events="33" subjects_affected="32" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dyskinesias And Movement Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Encephalopathies</sub_title>
                <counts group_id="E1" events="29" subjects_affected="27" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Encephalopathies Toxic And Metabolic</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Facial Cranial Nerve Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Generalised Tonic-Clonic Seizures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Headaches</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hydrocephalic Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Cord And Nerve Root Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Memory Loss (Excl Dementia)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mental Impairment (Excl Dementia And Memory Loss)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mononeuropathies</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Motor Neurone Diseases</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Multiple Sclerosis Acute And Progressive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Myelitis (Incl Infective)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nervous System Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Neurological Signs And Symptoms</sub_title>
                <counts group_id="E1" events="34" subjects_affected="32" subjects_at_risk="1257"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="19" subjects_affected="18" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Neuromuscular Junction Dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Paralysis And Paresis (Excl Cranial Nerve)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Parkinson's Disease And Parkinsonism</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peripheral Neuropathies</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Seizures And Seizure Disorders</sub_title>
                <counts group_id="E1" events="18" subjects_affected="12" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Sensory Abnormalities</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Speech And Language Abnormalities</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Spinal Cord And Nerve Root Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Structural Brain Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Transient Cerebrovascular Events</sub_title>
                <counts group_id="E1" events="34" subjects_affected="30" subjects_at_risk="1257"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="27" subjects_affected="24" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Tremor (Excl Congenital)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Trigeminal Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vagus Nerve Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal Behaviour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Anxiety Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Anxiety Symptoms</sub_title>
                <counts group_id="E1" events="10" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Behaviour And Socialisation Disturbances</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bipolar Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Confusion And Disorientation</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="1257"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="367"/>
                <counts group_id="E3" events="20" subjects_affected="20" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Deliria</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Delusional Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Depressive Disorders</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Disturbances In Initiating And Maintaining Sleep</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Eating Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mental Disorders</sub_title>
                <counts group_id="E1" events="64" subjects_affected="56" subjects_at_risk="1257"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="367"/>
                <counts group_id="E3" events="29" subjects_affected="29" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Panic Attacks And Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Perception Disturbances</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Psychiatric Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Speech Articulation And Rhythm Disturbances</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Stress Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Substance-Related Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Suicidal And Self-Injurious Behaviour</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder And Urethral Symptoms</sub_title>
                <counts group_id="E1" events="57" subjects_affected="51" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="49" subjects_affected="48" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bladder Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Genital And Urinary Tract Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Myoneurogenic Bladder Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nephropathies And Tubular Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Failure And Impairment</sub_title>
                <counts group_id="E1" events="263" subjects_affected="208" subjects_at_risk="1257"/>
                <counts group_id="E2" events="94" subjects_affected="76" subjects_at_risk="367"/>
                <counts group_id="E3" events="181" subjects_affected="154" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Failure Complications</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Lithiasis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Neoplasms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Obstructive Disorders</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Vascular And Ischaemic Conditions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Structural And Obstructive Urethral Disorders (Excl Congenital)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ureteric Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Abnormalities</sub_title>
                <counts group_id="E1" events="33" subjects_affected="29" subjects_at_risk="1257"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="367"/>
                <counts group_id="E3" events="36" subjects_affected="29" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Tract Lithiasis (Excl Renal)</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cervix Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ovarian And Fallopian Tube Cysts And Neoplasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pelvis And Broad Ligament Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Penile And Scrotal Infections And Inflammations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Penile Disorders (Excl Erection And Ejaculation)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Prostatic Neoplasms And Hypertrophy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Prostatic Signs, Symptoms And Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Reproductive Tract Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Scrotal Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Testicular And Epididymal Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Disorders</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vulvovaginal Signs And Symptoms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Abnormalities</sub_title>
                <counts group_id="E1" events="121" subjects_affected="101" subjects_at_risk="1257"/>
                <counts group_id="E2" events="39" subjects_affected="31" subjects_at_risk="367"/>
                <counts group_id="E3" events="76" subjects_affected="66" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bronchial Conditions</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Bronchospasm And Obstruction</sub_title>
                <counts group_id="E1" events="94" subjects_affected="55" subjects_at_risk="1257"/>
                <counts group_id="E2" events="40" subjects_affected="26" subjects_at_risk="367"/>
                <counts group_id="E3" events="42" subjects_affected="35" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Conditions Associated With Abnormal Gas Exchange</sub_title>
                <counts group_id="E1" events="26" subjects_affected="25" subjects_at_risk="1257"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="367"/>
                <counts group_id="E3" events="23" subjects_affected="22" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Coughing And Associated Symptoms</sub_title>
                <counts group_id="E1" events="20" subjects_affected="18" subjects_at_risk="1257"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Disorders</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Laryngeal And Adjacent Sites Disorders (Excl Infections And Neoplasms)</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Laryngeal Spasm, Oedema And Obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Inflammatory And Immunologic Conditions</sub_title>
                <counts group_id="E1" events="37" subjects_affected="34" subjects_at_risk="1257"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Signs And Symptoms</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Mediastinal Disorders</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nasal Disorders</sub_title>
                <counts group_id="E1" events="20" subjects_affected="17" subjects_at_risk="1257"/>
                <counts group_id="E2" events="12" subjects_affected="11" subjects_at_risk="367"/>
                <counts group_id="E3" events="15" subjects_affected="14" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Parenchymal Lung Disorders</sub_title>
                <counts group_id="E1" events="14" subjects_affected="13" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pharyngeal Disorders (Excl Infections And Neoplasms)</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pleural Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pneumothorax And Pleural Effusions</sub_title>
                <counts group_id="E1" events="137" subjects_affected="106" subjects_at_risk="1257"/>
                <counts group_id="E2" events="91" subjects_affected="70" subjects_at_risk="367"/>
                <counts group_id="E3" events="92" subjects_affected="75" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertensions</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="9" subjects_affected="8" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedemas</sub_title>
                <counts group_id="E1" events="34" subjects_affected="31" subjects_at_risk="1257"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="367"/>
                <counts group_id="E3" events="40" subjects_affected="35" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pulmonary Thrombotic And Embolic Conditions</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory Failures (Excl Neonatal)</sub_title>
                <counts group_id="E1" events="192" subjects_affected="149" subjects_at_risk="1257"/>
                <counts group_id="E2" events="77" subjects_affected="66" subjects_at_risk="367"/>
                <counts group_id="E3" events="126" subjects_affected="108" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Disorders</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Signs And Symptoms</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bullous Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dermal And Epidermal Conditions</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Dermatitis And Eczema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Erythemas</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Exfoliative Conditions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Hyperkeratoses</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nail And Nail Bed Conditions (Excl Infections And Infestations)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Purpura And Related Conditions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Rashes, Eruptions And Exanthems</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin And Subcutaneous Conditions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin And Subcutaneous Tissue Ulcerations</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Injuries And Mechanical Dermatoses</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Preneoplastic Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Vasculitides</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Skin Vasomotor Conditions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Arterial Therapeutic Procedures (Excl Aortic)</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Cardiac Device Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Haematological Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Joint Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Large Intestine Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lens Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Prostatic Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Therapeutic Bladder Catheterisation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="22" subjects_affected="20" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Tracheal Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Venous Therapeutic Procedures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated And Malignant Hypertension</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Aneurysms And Dissections Non-Site Specific</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysms And Dissections</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="1257"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Aortic Embolism And Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Aortic Necrosis And Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Arterial And Aortic Injuries</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="10" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Arterial Inflammations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Blood Pressure Disorders</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Circulatory Collapse And Shock</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Haemorrhages</sub_title>
                <counts group_id="E1" events="43" subjects_affected="43" subjects_at_risk="1257"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="367"/>
                <counts group_id="E3" events="34" subjects_affected="33" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lymphangiopathies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Lymphoedemas</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Embolism And Thrombosis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1257"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="367"/>
                <counts group_id="E3" events="7" subjects_affected="7" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Necrosis And Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Vascular Disorders</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="1257"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="367"/>
                <counts group_id="E3" events="12" subjects_affected="12" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peripheral Aneurysms And Dissections</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="1257"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="367"/>
                <counts group_id="E3" events="11" subjects_affected="11" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism And Thrombosis</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="367"/>
                <counts group_id="E3" events="19" subjects_affected="17" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorders</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="1257"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="367"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Peripheral Vasoconstriction, Necrosis And Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="37" subjects_affected="35" subjects_at_risk="1257"/>
                <counts group_id="E2" events="17" subjects_affected="16" subjects_at_risk="367"/>
                <counts group_id="E3" events="44" subjects_affected="41" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Site Specific Necrosis And Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Site Specific Vascular Disorders</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1257"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="367"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Hypertensive Disorders</sub_title>
                <counts group_id="E1" events="60" subjects_affected="54" subjects_at_risk="1257"/>
                <counts group_id="E2" events="23" subjects_affected="22" subjects_at_risk="367"/>
                <counts group_id="E3" events="57" subjects_affected="53" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Hypotensive Disorders</sub_title>
                <counts group_id="E1" events="157" subjects_affected="137" subjects_at_risk="1257"/>
                <counts group_id="E2" events="52" subjects_affected="50" subjects_at_risk="367"/>
                <counts group_id="E3" events="93" subjects_affected="90" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Malformations And Acquired Anomalies</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1257"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="367"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 14.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1097" subjects_at_risk="1257"/>
                <counts group_id="E2" subjects_affected="327" subjects_at_risk="367"/>
                <counts group_id="E3" subjects_affected="1001" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemias</sub_title>
                <counts group_id="E1" events="259" subjects_affected="244" subjects_at_risk="1257"/>
                <counts group_id="E2" events="96" subjects_affected="92" subjects_at_risk="367"/>
                <counts group_id="E3" events="267" subjects_affected="260" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Leukocytoses</sub_title>
                <counts group_id="E1" events="88" subjects_affected="82" subjects_at_risk="1257"/>
                <counts group_id="E2" events="40" subjects_affected="38" subjects_at_risk="367"/>
                <counts group_id="E3" events="81" subjects_affected="79" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Thrombocytopenias</sub_title>
                <counts group_id="E1" events="182" subjects_affected="175" subjects_at_risk="1257"/>
                <counts group_id="E2" events="74" subjects_affected="70" subjects_at_risk="367"/>
                <counts group_id="E3" events="223" subjects_affected="217" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Conduction Disorders</sub_title>
                <counts group_id="E1" events="335" subjects_affected="286" subjects_at_risk="1257"/>
                <counts group_id="E2" events="65" subjects_affected="56" subjects_at_risk="367"/>
                <counts group_id="E3" events="387" subjects_affected="331" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Heart Failures</sub_title>
                <counts group_id="E1" events="107" subjects_affected="96" subjects_at_risk="1257"/>
                <counts group_id="E2" events="31" subjects_affected="30" subjects_at_risk="367"/>
                <counts group_id="E3" events="74" subjects_affected="68" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Rate And Rhythm Disorders</sub_title>
                <counts group_id="E1" events="92" subjects_affected="85" subjects_at_risk="1257"/>
                <counts group_id="E2" events="30" subjects_affected="28" subjects_at_risk="367"/>
                <counts group_id="E3" events="105" subjects_affected="99" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Supraventricular Arrhythmias</sub_title>
                <counts group_id="E1" events="174" subjects_affected="153" subjects_at_risk="1257"/>
                <counts group_id="E2" events="81" subjects_affected="72" subjects_at_risk="367"/>
                <counts group_id="E3" events="186" subjects_affected="159" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmias And Cardiac Arrest</sub_title>
                <counts group_id="E1" events="69" subjects_affected="64" subjects_at_risk="1257"/>
                <counts group_id="E2" events="16" subjects_affected="15" subjects_at_risk="367"/>
                <counts group_id="E3" events="69" subjects_affected="66" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal Atonic And Hypomotility Disorders</sub_title>
                <counts group_id="E1" events="70" subjects_affected="66" subjects_at_risk="1257"/>
                <counts group_id="E2" events="27" subjects_affected="27" subjects_at_risk="367"/>
                <counts group_id="E3" events="78" subjects_affected="74" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Nausea And Vomiting Symptoms</sub_title>
                <counts group_id="E1" events="61" subjects_affected="57" subjects_at_risk="1257"/>
                <counts group_id="E2" events="22" subjects_affected="19" subjects_at_risk="367"/>
                <counts group_id="E3" events="51" subjects_affected="45" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenic Conditions</sub_title>
                <counts group_id="E1" events="63" subjects_affected="57" subjects_at_risk="1257"/>
                <counts group_id="E2" events="25" subjects_affected="23" subjects_at_risk="367"/>
                <counts group_id="E3" events="44" subjects_affected="43" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Febrile Disorders</sub_title>
                <counts group_id="E1" events="77" subjects_affected="75" subjects_at_risk="1257"/>
                <counts group_id="E2" events="25" subjects_affected="24" subjects_at_risk="367"/>
                <counts group_id="E3" events="71" subjects_affected="69" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="102" subjects_affected="93" subjects_at_risk="1257"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="367"/>
                <counts group_id="E3" events="95" subjects_affected="85" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pain And Discomfort</sub_title>
                <counts group_id="E1" events="86" subjects_affected="72" subjects_at_risk="1257"/>
                <counts group_id="E2" events="29" subjects_affected="22" subjects_at_risk="367"/>
                <counts group_id="E3" events="84" subjects_affected="71" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Lower Respiratory Tract And Lung Infections</sub_title>
                <counts group_id="E1" events="75" subjects_affected="67" subjects_at_risk="1257"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="367"/>
                <counts group_id="E3" events="58" subjects_affected="55" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infections</sub_title>
                <counts group_id="E1" events="182" subjects_affected="149" subjects_at_risk="1257"/>
                <counts group_id="E2" events="46" subjects_affected="45" subjects_at_risk="367"/>
                <counts group_id="E3" events="164" subjects_affected="141" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Non-Site Specific Injuries</sub_title>
                <counts group_id="E1" events="93" subjects_affected="86" subjects_at_risk="1257"/>
                <counts group_id="E2" events="19" subjects_affected="16" subjects_at_risk="367"/>
                <counts group_id="E3" events="77" subjects_affected="68" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Non-Site Specific Procedural Complications</sub_title>
                <counts group_id="E1" events="80" subjects_affected="74" subjects_at_risk="1257"/>
                <counts group_id="E2" events="27" subjects_affected="25" subjects_at_risk="367"/>
                <counts group_id="E3" events="92" subjects_affected="87" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Skeletal And Cardiac Muscle Analyses</sub_title>
                <counts group_id="E1" events="54" subjects_affected="52" subjects_at_risk="1257"/>
                <counts group_id="E2" events="26" subjects_affected="25" subjects_at_risk="367"/>
                <counts group_id="E3" events="43" subjects_affected="42" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemic Conditions</sub_title>
                <counts group_id="E1" events="34" subjects_affected="33" subjects_at_risk="1257"/>
                <counts group_id="E2" events="27" subjects_affected="27" subjects_at_risk="367"/>
                <counts group_id="E3" events="46" subjects_affected="46" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Magnesium Metabolism Disorders</sub_title>
                <counts group_id="E1" events="25" subjects_affected="25" subjects_at_risk="1257"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="367"/>
                <counts group_id="E3" events="65" subjects_affected="64" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Potassium Imbalance</sub_title>
                <counts group_id="E1" events="96" subjects_affected="84" subjects_at_risk="1257"/>
                <counts group_id="E2" events="35" subjects_affected="34" subjects_at_risk="367"/>
                <counts group_id="E3" events="99" subjects_affected="87" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Sodium Imbalance</sub_title>
                <counts group_id="E1" events="68" subjects_affected="61" subjects_at_risk="1257"/>
                <counts group_id="E2" events="29" subjects_affected="28" subjects_at_risk="367"/>
                <counts group_id="E3" events="63" subjects_affected="58" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Total Fluid Volume Increased</sub_title>
                <counts group_id="E1" events="89" subjects_affected="85" subjects_at_risk="1257"/>
                <counts group_id="E2" events="28" subjects_affected="28" subjects_at_risk="367"/>
                <counts group_id="E3" events="122" subjects_affected="116" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal And Connective Tissue Pain And Discomfort</sub_title>
                <counts group_id="E1" events="100" subjects_affected="89" subjects_at_risk="1257"/>
                <counts group_id="E2" events="33" subjects_affected="29" subjects_at_risk="367"/>
                <counts group_id="E3" events="108" subjects_affected="99" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Confusion And Disorientation</sub_title>
                <counts group_id="E1" events="59" subjects_affected="57" subjects_at_risk="1257"/>
                <counts group_id="E2" events="24" subjects_affected="24" subjects_at_risk="367"/>
                <counts group_id="E3" events="69" subjects_affected="68" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Bladder And Urethral Symptoms</sub_title>
                <counts group_id="E1" events="35" subjects_affected="35" subjects_at_risk="1257"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="367"/>
                <counts group_id="E3" events="60" subjects_affected="57" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Renal Failure And Impairment</sub_title>
                <counts group_id="E1" events="199" subjects_affected="165" subjects_at_risk="1257"/>
                <counts group_id="E2" events="66" subjects_affected="58" subjects_at_risk="367"/>
                <counts group_id="E3" events="223" subjects_affected="201" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Abnormalities</sub_title>
                <counts group_id="E1" events="81" subjects_affected="77" subjects_at_risk="1257"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="367"/>
                <counts group_id="E3" events="67" subjects_affected="64" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Parenchymal Lung Disorders</sub_title>
                <counts group_id="E1" events="75" subjects_affected="72" subjects_at_risk="1257"/>
                <counts group_id="E2" events="25" subjects_affected="25" subjects_at_risk="367"/>
                <counts group_id="E3" events="98" subjects_affected="94" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pneumothorax And Pleural Effusions</sub_title>
                <counts group_id="E1" events="146" subjects_affected="138" subjects_at_risk="1257"/>
                <counts group_id="E2" events="73" subjects_affected="64" subjects_at_risk="367"/>
                <counts group_id="E3" events="187" subjects_affected="168" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedemas</sub_title>
                <counts group_id="E1" events="70" subjects_affected="68" subjects_at_risk="1257"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="367"/>
                <counts group_id="E3" events="69" subjects_affected="67" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haemorrhages</sub_title>
                <counts group_id="E1" events="57" subjects_affected="55" subjects_at_risk="1257"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="367"/>
                <counts group_id="E3" events="62" subjects_affected="61" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Hypertensive Disorders</sub_title>
                <counts group_id="E1" events="152" subjects_affected="146" subjects_at_risk="1257"/>
                <counts group_id="E2" events="58" subjects_affected="56" subjects_at_risk="367"/>
                <counts group_id="E3" events="206" subjects_affected="192" subjects_at_risk="1108"/>
              </event>
              <event>
                <sub_title>Vascular Hypotensive Disorders</sub_title>
                <counts group_id="E1" events="162" subjects_affected="146" subjects_at_risk="1257"/>
                <counts group_id="E2" events="49" subjects_affected="45" subjects_at_risk="367"/>
                <counts group_id="E3" events="131" subjects_affected="120" subjects_at_risk="1108"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hatice Bilgic Lim</name_or_title>
      <organization>Medtronic, Inc.</organization>
      <email>rs.medtroniccardiovascularclinicaltrials@medtronic.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

